Patents by Inventor Jinpeng Zhao

Jinpeng Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10961266
    Abstract: A chemoselective and reactive Mn(CF3-PDP) catalyst system that enables for the first time the strategic advantages of late-stage aliphatic C—H hydroxylation to be leveraged in aromatic compounds. This discovery will benefit small molecule therapeutics by enabling the rapid diversification of aromatic drugs and natural products and identification of their metabolites.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: March 30, 2021
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: M. Christina White, Jinpeng Zhao
  • Publication number: 20200087331
    Abstract: A chemoselective and reactive Mn(CF3-PDP) catalyst system that enables for the first time the strategic advantages of late-stage aliphatic C—H hydroxylation to be leveraged in aromatic compounds. This discovery will benefit small molecule therapeutics by enabling the rapid diversification of aromatic drugs and natural products and identification of their metabolites.
    Type: Application
    Filed: September 12, 2019
    Publication date: March 19, 2020
    Inventors: M. Christina WHITE, Jinpeng ZHAO
  • Patent number: 9770711
    Abstract: The invention provides novel manganese catalysts such as [Mn(tBuPc)], which are general for the amination of all types of C(sp3)-H bonds (aliphatic, allylic, propargylic, benzylic, ethereal), including strong 1o aliphatic C—H bonds, while achieving excellent chemoselectivity, stereospecificity, and high functional group tolerance. We demonstrate the late-stage diversification of bioactive complex molecules that encompass the range of C(sp3)-H bond types, such as selective 1o C—H aminations of betulinic acid and pleuromutilin derivatives. The catalysts' unprecedented balance of reactivity and selectivity is in part attributed to its mechanism of C—H amination that lies between stepwise and concerted.
    Type: Grant
    Filed: March 21, 2016
    Date of Patent: September 26, 2017
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: M. Christina White, Shauna M. Paradine, Jennifer R. Griffin, Jinpeng Zhao, Aaron L. Petronico
  • Publication number: 20160272662
    Abstract: The invention provides novel manganese catalysts such as [Mn(tBuPc)], which are general for the amination of all types of C(sp3)-H bonds (aliphatic, allylic, propargylic, benzylic, ethereal), including strong 1o aliphatic C—H bonds, while achieving excellent chemoselectivity, stereospecificity, and high functional group tolerance. We demonstrate the late-stage diversification of bioactive complex molecules that encompass the range of C(sp3)-H bond types, such as selective 1o C—H aminations of betulinic acid and pleuromutilin derivatives. The catalysts' unprecedented balance of reactivity and selectivity is in part attributed to its mechanism of C—H amination that lies between stepwise and concerted.
    Type: Application
    Filed: March 21, 2016
    Publication date: September 22, 2016
    Applicant: The Board of Trustees of the University of Illinois
    Inventors: M. Christina White, Shauna M. Paradine, Jennifer R. Griffin, Jinpeng Zhao, Aaron L. Petronico